GOODWILL AND INTANGIBLE ASSETS (Tables)

9 Months Ended

Jun. 29, 2018

Goodwill and Intangible Assets Disclosure [Abstract]

Activity of Goodwill by Reportable Operating Segment

The following table reflects the activity of goodwill by reportable operating segment: 

(In millions)	Oncology Systems		Varian Particle Therapy			Total
Balance at September 29, 2017	$	170.2	$	52.4		$	222.6
Business combinations	17.9		—			17.9
Foreign currency translation adjustments	—		(0.6		)	(0.6		)
Balance at June 29, 2018	$	188.1	$	51.8		$	239.9

Schedule of Indefinite-Lived Intangible Assets

The following table reflects the gross carrying amount and accumulated amortization of the Company's intangible assets: 

	June 29, 2018							September 29, 2017
(In millions)	Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount
Technologies and patents	$	115.5	$	(70.6	)	$	44.9	$	102.0	$	(60.9	)	$	41.1
Customer contracts and supplier relationship	42.8		(17.6		)	25.2		33.9		(14.3		)	19.6
Other	5.7		(5.2		)	0.5		5.5		(3.4		)	2.1
Total intangible with finite lives	164.0		(93.4		)	70.6		141.4		(78.6		)	62.8
In-process research and development with indefinite lives	8.8		—			8.8		8.8		—			8.8
Total intangible assets	$	172.8	$	(93.4	)	$	79.4	$	150.2	$	(78.6	)	$	71.6

Gross Carrying Amount and Accumulated Amortization of Intangible Assets

The following table reflects the gross carrying amount and accumulated amortization of the Company's intangible assets: 

	June 29, 2018							September 29, 2017
(In millions)	Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount
Technologies and patents	$	115.5	$	(70.6	)	$	44.9	$	102.0	$	(60.9	)	$	41.1
Customer contracts and supplier relationship	42.8		(17.6		)	25.2		33.9		(14.3		)	19.6
Other	5.7		(5.2		)	0.5		5.5		(3.4		)	2.1
Total intangible with finite lives	164.0		(93.4		)	70.6		141.4		(78.6		)	62.8
In-process research and development with indefinite lives	8.8		—			8.8		8.8		—			8.8
Total intangible assets	$	172.8	$	(93.4	)	$	79.4	$	150.2	$	(78.6	)	$	71.6

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense

As of June 29, 2018, the Company estimates its remaining amortization expense for intangible assets with finite lives will be as follows (in millions):

Fiscal Years:	Remaining Amortization Expense
Remainder of 2018	$	4.7
2019	16.3
2020	14.0
2021	10.6
2022	9.2
Thereafter	15.8
Total remaining amortization for intangible assets	$	70.6